Just a moment...
We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic
• Quick overview summary answering your query with references
• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced
• Includes everything in Basic
• Detailed report covering:
- Overview Summary
- Governing Provisions [Acts, Notifications, Circulars]
- Relevant Case Laws
- Tariff / Classification / HSN
- Expert views from TaxTMI
- Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.
Help Us Improve - by giving the rating with each AI Result:
Powered by Weblekha - Building Scalable Websites
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
1. ISSUES PRESENTED AND CONSIDERED
1. Whether the use of the collaborator's name and the inscription "In collaboration with [foreign company]" on a product label amounts to using "the brand name or trade name of another person" within the meaning of the relevant SSI exemption Notifications (para-7 of Notification 175/86-C.E. and para-4 of Notification 1/93-C.E.), thereby disentitling the manufacturer to exemption.
2. Whether highlighting a word that is both part of the domestic manufacturer's company name and the foreign collaborator's name (e.g., the element "Goldhofer" displayed prominently in the manufacturer's name/logo) converts the label into the brand/trade name of another person for purposes of denial of SSI benefit.
3. Whether an express contractual obligation to affix a label stating that the product is "manufactured under licence/from [foreign company]" can be construed as use of another's brand/trade name so as to attract the bar in the Notifications.
4. Whether earlier Tribunal decisions addressing similar inscriptions on product labels are applicable and, if so, whether they should be followed.
2. ISSUE-WISE DETAILED ANALYSIS
Issue 1 - Whether inscription "In collaboration with [foreign company]" equals use of another's brand/trade name under the Notifications
Legal framework: The Notifications grant SSI exemption subject to exclusions where goods are cleared "under the brand name or trade name of another person" (see para-7 of Notification 175/86-C.E. and corresponding para-4 of Notification 1/93-C.E.). The definition/explanation of "brand name / trade name" (Explanation VIII to Notification 175/86-C.E. and the corresponding Explanation in Notification 1/93-C.E.) governs interpretation.
Precedent treatment: Tribunal decisions (Weigand India (P) Ltd.; Prestige Counting Instruments P. Ltd.; Esprit Switchgear Pvt. Ltd.; Rajdoot Paints Ltd.) held that inscriptions indicating technical collaboration or manufacture under licence do not amount to use of the foreign collaborator's brand/trade name and allowed SSI benefit.
Interpretation and reasoning: The Court examined the label text and the contractual clause requiring a permanent label stating "Manufactured under the licence from [foreign company]" or equivalent marking. The Court held the plain meaning of the inscription is to denote technical collaboration or licence-based manufacture, not to assert that the product carries the foreign company's brand. The Revenue failed to establish that the inscription operated as the brand name of the foreign company in the market or that the inscription created identity of goods with the collaborator's branded products.
Ratio vs. Obiter: Ratio - an inscription stating collaboration/licence does not, by itself, constitute use of another person's brand/trade name under the Notifications; this is the determinative legal proposition applied to deny the Revenue's contention. Observational remarks about intentions of parties and ordinary meaning of the label are explanatory.
Conclusion: The inscription "In collaboration with [foreign company]" is not equivalent to using another's brand/trade name for the purposes of excluding SSI exemption; exemption cannot be denied on that basis.
Issue 2 - Effect of highlighting a word common to both the domestic company name and the foreign collaborator's name
Legal framework: Same statutory Notifications and explanatory provisions governing what constitutes "brand name / trade name."
Precedent treatment: The Court relied upon the cited Tribunal authorities which treated similar factual situations (nameplates, housemarks, and inscriptions of collaboration) as not amounting to third-party brand use.
Interpretation and reasoning: The Court noted that the highlighted word formed part of the manufacturer's corporate name as registered and used by the domestic manufacturer. Mere prominence or bolding of that element on the product label, especially in tandem with express collaborative/licence wording, does not convert the manufacturer's own name into the brand of another person. The Court required positive establishment by Revenue that the highlighted term functioned in the market as the collaborator's brand; Revenue did not discharge that burden.
Ratio vs. Obiter: Ratio - prominence of a word that is part of the manufacturer's name does not automatically render the product cleared "under the brand name or trade name of another person" absent evidence that the word functions in the market as another's brand.
Conclusion: Highlighting the collaborator's name element within the manufacturer's company name does not, without further proof, attract the Notifications' exclusion.
Issue 3 - Effect of contractual label requirement stating "manufactured under licence" on entitlement to SSI exemption
Legal framework: Contractual obligation to indicate licence or collaboration bears on the meaning of the product label; however statutory test remains whether the goods are cleared under another's brand/trade name.
Precedent treatment: Tribunal authorities cited held that contractual or factual inscriptions of technical collaboration/licence do not amount to brand usage by another person.
Interpretation and reasoning: The Court construed the contractual clause mandating a label as intending to communicate that the goods were manufactured under licence from the foreign collaborator. That factual statement, being literal and unambiguous, leaves no scope for interpreting the label as an assertion of brand ownership by the foreign collaborator. The contractual label provision therefore supports the conclusion that the inscription denotes licence/collaboration rather than brand use.
Ratio vs. Obiter: Ratio - compliance with a contractual duty to state manufacture under licence is consistent with entitlement to SSI exemption and does not transform products into being cleared under another's brand.
Conclusion: An express contractual requirement to affix a "manufactured under licence" label does not disqualify the manufacturer from SSI exemption under the Notifications.
Issue 4 - Applicability and effect of prior Tribunal decisions
Legal framework: Administrative/tribunal precedents interpreting identical or substantially similar label inscriptions under the Notifications provide persuasive authority for consistent treatment of similar factual patterns.
Precedent treatment: The Court expressly followed the line of Tribunal decisions in Weigand, Prestige Counting, Esprit Switchgear and Rajdoot Paints, which uniformly held that inscriptions of collaboration or manufacture under licence are not use of another's brand and therefore do not attract the exclusion in the Notifications.
Interpretation and reasoning: The Court found the facts and legal questions in those authorities to be analogous and adopted their reasoning. No distinguishing features were found in the impugned matters that warranted departing from those precedents.
Ratio vs. Obiter: Ratio - prior Tribunal decisions were followed and applied to permit SSI benefit in the present appeals.
Conclusion: The Tribunal precedents were applicable and followed; they support allowing the exemption in the present cases.
Collateral point - Time-bar/limitation
Legal framework: Limitation arguments were raised below (invocation of longer limitation under proviso to Section 11A(1) in adjudication), but the Court expressly did not decide the time-bar issue because the appeals were allowed on merits.
Interpretation and reasoning: The Court stated the time-bar issue need not be addressed given the merits ruling.
Ratio vs. Obiter: Obiter - non-decision on limitation; no precedential effect regarding time-bar.
Conclusion: Time-bar was left open and not adjudicated.
Final holding
The Court set aside the impugned orders and allowed the appeals on merits, holding that the product labels indicating collaboration/manufacture under licence and the prominence of a name element shared with the foreign collaborator did not amount to use of another person's brand/trade name so as to deny SSI exemption under the relevant Notifications.